Definiens

Definiens was awarded Frost & Sullivan's 2013 Global Company of the Year for Tissue Diagnostics and Pathology Imaging Solutions. Definiens is the leading provider of image analysis and data mining solutions for quantitative digital pathology in the life sciences, diagnostic biomarkers and healthcare industries. Definiens software provides detailed readouts from whole tissue slides, cell-based assays and full body scans and allows correlating this information with data derived from other sources. By automating analysis workflows, Definiens helps pharmaceutical and biotechnology companies, research institutions, clinical service organizations and pathologists to generate new knowledge and supports better decisions in research, diagnostics and therapy. Definiens vision is to open new fields of research, to contribute to development of personalized medicine and to significantly improve the quality of patients lives. Definiens software frees clinicians and scientists from poring over images, enabling them to focus on the critical work of investigation and interpretation: Clinicians can provide more accurate and informed patient care based on highly detailed and rich analysis of tissue slides or full body scans. Scientists can run any size of study and correlate the image data with other types of information, such as experimental conditions or patient outcomes. This allows them to understand the mechanisms of disease, validate targets, identify relevant biomarkers and open new avenues of research. As the amount of image data grows exponentially, automation of image and data analysis is the only way to reduce the information bottleneck. Definiens revolutionary technology provides unprecedented accuracy in identifying and quantifying biological attributes within images and turning them into knowledge. Definiens is headquartered in Munich, Germany, and has a North American office in Carlsbad, California.